Rapt Therapeutics Inc (RAPT)

57.96 +0.04%

Rapt Therapeutics Inc (RAPT) is currently trading at $57.96. This represents a gain of 0.04% from the previous session. With a market capitalization of $1.68B, RAPT is a key component of the Health Care sector. Investors looking to trade RAPT should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade RAPT commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Rapt Therapeutics Inc (RAPT) shows a bullish trend. Analysts are watching the 57.96 level closely.

Fundamentals
Mkt Cap1.68B
P/E Ratio0.0000
Volume1,957,904
Others Watching (By Market Cap)
ACAD
ACADIA Pharmace $24.80
+0.85% CRNX
Crinetics Pharm $44.10
-0.94% ALHC
Alignment Healt $19.96
+1.84% VKTX
Viking Therapeu $33.66
-0.33% ICUI
ICU Medical Inc $153.60
+0.74%
60-Day Technical Chart
Advanced Charting

Need more indicators for RAPT? Use the world's #1 platform.

Open RAPT on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $58
Metric RAPT
+0.04% 		TEM
-7.13% 		BMY
-0.81% 		CTSH
+0.14%
Price $57.96 $53.85 $61.11 $61.16
Mkt Cap $1.68B $9.58B $124.47B $29.25B
- View → View → View →
Latest Headlines
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges Yahoo Finance • Feb 25, 2026 Rapt Therapeutics stock hits 52-week high at 57.87 USD Investing.com • Feb 19, 2026 Why Rapt Therapeutics Stock Soared Today The Motley Fool • Jan 20, 2026 GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug Reuters • Jan 20, 2026 Top 2% Biotech Rockets After Topping Roche In A Key Test Investor's Business Daily • Oct 20, 2025
● Gemini Agentic AI Analyst Insight for RAPT
Market Education
View All Articles →
External Research